Page 1

Progress Check on Emerging Markets

What Happens as Developing Markets Develop?

The world is going through a transitional period, and investors are revisiting their views of and exposure to emerging markets. There has been considerable change in the last decade, with geopolitical shifts, Covid closures, and emerging opportunities.  Whether it’s the rise of the Middle East, India’s population growth outpacing China, or China evolving into its own category – topics of discussion are endless. Progress Check on Emerging Markets unpacks latest investor sentiment and areas of interest in these rapidly shifting asset classes.

May 24, 2023

See Disclosure

Digital Health: Below the Surface

Digital health is the latest healthcare theme capturing investors’ attention. Data breakthroughs in life sciences have been around for decades (Think: CRISPR DNA editing), but our healthcare systems are going through a complete digital transformation in the wake of Covid-19. Digital Health: Below the Surface, unpacks the digital health universe, the institutional investor landscape, and how this area differs from other sub-sectors in life sciences.

April 10, 2023

See Disclosure

Uncertainty & the Value Proposition of Hedge Funds

In 2022, hedge funds had their best year of outperformance in over a decade. Investors are curious how hedge funds will navigate further volatility, uncertainty, and unexpected market events. The Value Proposition for Allocations to Hedge Funds investigates how managers have outperformed during market turbulence and what role they may play in allocators’ portfolios in the year ahead.

March 30, 2023

See Disclosure

Capital Raising in a Transition

The Road to 2025

Allocators are looking for the right partner for the next decade, with billions at stake. While PMs and risk managers remain laser focused on adapting portfolios to navigate rate rises, unpredictable markets and currency risk, marketing and IR decision makers are developing new strategies to build more enduring asset bases and LP pipelines. Capital Raising in a Transition addresses the people, policies and processes that are developing next generation asset growth and retention strategies.

March 8, 2023

See Disclosure

Capitalizing on Consciousness?

Innovative Mental Health Solutions

Our severe and growing mental health crisis impacts over a billion lives, with over $1 trillion in annual costs. The field of psychedelic medicine gives some investors hope we may be on the cusp of a mental health treatment breakthrough. Our latest piece explores this area of Biotech which has recently seen advances in drug development, institutional investment, and state legalization.

November 10, 2022

See Disclosure

Healthcare Alternatives Landscape

The Road to Half a Trillion

The Jefferies Prime Services team recently conducted a deep dive across the healthcare alternative funds competitive landscape. Across many topics explored, it is clear healthcare funds have evolved and matured considerably in recent years. Read the executive summary of our findings, and for access to the full suite of data and analysis - contact your Jefferies salesperson.

November 3, 2022

See Disclosure

Illustration, multicolored graphics overlay each other, financial data, bar charts, line graphs and silhouette of the earths continents

Whiplash 2022

Navigating Markets Both Familiar and Foreign

Headlines are focused on perceived underperformance of hedge funds this year, however the opposite is true. After all, you can't compound capital you don't preserve. Whiplash 2022 explores first half market performance, and why outperformance matters in these scenarios – even if it comes from unlikely places.

August 4, 2022

See Disclosure